Gundersen Health System — La Crosse, Wisconsin

Public research footprint of Gundersen Health System, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Geographic Atrophy Secondary to Age-related Macular Degeneration · Non-small Cell Lung Cancer · Center Involved Diabetic Macular Edema · Venous Leg Ulcer

Recently updated registry entries

NCT07144137 — A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA) (Recruiting)
NCT05407636 — Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (Active Not Recruiting)
NCT05802329 — Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Gundersen Health System?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.